MYD88 and Waldenstrom macroglobulinemia: Waldenstrom macroglobulinemia (WM) is an indolent yet incurable B-cell lymphoma, in which aberrant B-cell receptor (BCR), Toll-like receptor and MYD88 signaling cooperatively drive tumor cell survival.